Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Detection of the different phases of Mycobacterium tuberculosis infection and prediction of the development of tuberculosis disease progression by application of novel interferon gamma release assay

Descrizione del progetto

Test innovativo per il rilevamento delle fasi dell’infezione tubercolare e della progressione della malattia

La tubercolosi (TB) ha un alto tasso di mortalità a causa della capacità del batterio Mycobacterium tuberculosis (Mtb) di nascondersi dopo l’infezione e della mancanza di test accurati e sensibili per rilevare le diverse forme di TB e la progressione della malattia. Il progetto DET-TB, finanziato dall’UE, intende determinare e studiare nuovi antigeni che potrebbero essere utilizzati per individuare le fasi dell’infezione da Mtb e come strumento prognostico accurato. L’obiettivo principale è quello di comprendere meglio i meccanismi molecolari dell’infezione tubercolare e di identificare nuovi antigeni per la progettazione di nuovi test di rilascio dell’interferone-gamma per il rilevamento delle diverse fasi dell’infezione e della progressione della malattia.

Obiettivo

Tuberculosis disease (TB) is the second leading infectious killer after COVID-19 (above HIV/AIDS). The main reason is due to high ability of the bacteria Mycobacterium tuberculosis (Mtb) to hide after infection and lack of the precise and sensitive tests able to detect different forms of TB and indicate disease progression. Therefore the aim of this project is to search and investigate new antigens that could be used not only for the detection of different phases of Mycobacterium tuberculosis infection but also could be used for precise prognostic tool. To achieve this goal, the experience of the applicant in a LTBI diagnostics, medical microbiology and molecular biology will be combined with hands on training in a field of bioinformatics, and in silico approaches supported by artificial intelligence computational and experimental methods applied for structural analysis of proteins supporting strategic decisions in detection system development.
As part of the World Health Organization's (WHO) End TB Strategy to reduce the mortality and incidence rates of TB by 90% and 80%, respectively, in 2025 and further reduction by 95% and 90% in 2035, reverse efforts to focus on TB infection management as one of the TB preventive care approaches for the long-term situation of TB prevention and treatment are highly needed.
The main goal of this proposal is to better understand molecular basic of the TB infection and progression aiming identification of the new antigens which later can provide a new avenue for designing of novel interferon gamma release assays (IGRA) test for detection of different phases of TB infection and predict active TB disease progression. We hypothesise that using latency associated protein candidates and IFN-γ-producing CD8+ T cells specific Mtb antigens we will be able to achieve these goals.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-WIDERA-2022-TALENTS-04

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

POLITECHNIKA SLASKA
Contributo netto dell'UE
€ 155 793,60
Indirizzo
AKADEMICKA STREET 2A
44-100 GLIWICE
Polonia
Regione
Makroregion południowy Śląskie Katowicki
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato